Press releases

6
Jul

Genoskin launches the ISR platform®

Genoskin launches the ISR platform®: the first human skin ex vivo platform to study injection site reactions (ISR) ahead of clinical trials Genoskin is evolving and aims to support the biotech and pharmaceutical industries in accelerating their drug development. Today, July 6th 2021, Genoskin announces the launch of the ISR platform®, a new pre-clinical toolbox designed to study injection site
Read more
4
Sep

Genoskin launches new offering: NativeSkin access

Genoskin launches new skin offering, NativeSkin® access, that increases accessibility to animal testing alternatives NativeSkin, the only ex vivo human skin model sold online, will be available to purchase daily at a key price point, making it easier to order even for larger volume sales Toulouse, France & Salem, MA, USA, September 1, 2020 - Genoskin, a biotechnology company developing ready-to-use human skin
Read more
18
Sep

Genemarkers and Genoskin announce new partnership

Genemarkers, LLC and Genoskin, Inc. announce partnership to advance clinical studies of topical solutions September 18, 2019 - Kalamazoo, MI & Salem, MA Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work to
Read more
4
Jan

Genoskin expands leadership team

Genoskin appoints Eric Merle as first chief commercial officer   Salem, MA. – January 4, 2019 – Genoskin, an innovative provider of ex vivo clinical testing skin models and solutions, announced today the addition of Eric Merle as the company’s first chief commercial officer. The new position will see him take responsibility for all regions in which Genoskin operates. Eric has

Read more

29
Aug

Genoskin brings unique alternative to animal testing to the US

Skin biotech to set up Boston production unit that recycles excess human skin Toulouse, France, August 29, 2017 – Genoskin, a company that provides a cutting-edge alternative to animal testing by keeping donated human skin alive, today announces its expansion into North America. The biotech has established a representative office in Boston and plans to open a local production unit
Read more
2
Mar

Genoskin finalist of Start-Up Connexion 2017

On February 3, 2017, Genoskin was awarded a finalist spot in the third edition of the Start-up Connexion Contest. This event brings together innovative research companies and potential investors to highlight and finance projects with high economic value. The Start-up Connexion Contest is a combined initiative of the CNRS (French National Center for Scientific Research) and the AEF Media Group, which specializes in

Read more